Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients
Completed
Conditions studied: Solid Tumor
In brief
RATIONALE: Studying samples of tissue and blood in the laboratory from patients with cancer receiving epidermal growth factor receptor (EGFR) inhibitors may help doctors understand the effects of EGFR inhibitor therapy in the skin. PURPOSE: This laboratory study is looking at the effects of EGFR inhibitors in the skin of cancer patients.
Key facts
- Study ID
- NCT00483457
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 33
- Starts
- 2006-02-01
- Expected to finish
- 2008-11-01
- Last updated by the study team
- 2012-09-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.